Neuromyelitis optica: diagnosis, pathogenesis, and treatment (Q31172560)

29 June 2017

1 reference

title

Neuromyelitis optica: diagnosis, pathogenesis, and treatment (English)

1 reference

29 June 2017

1 reference

Bruce Cree

1

1 reference

29 June 2017

1 September 2008

1 reference

Current Neurology and Neuroscience Reports

29 June 2017

1 reference

29 June 2017

8

1 reference

29 June 2017

427-433

1 reference

29 June 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-008-0066-2

29 June 2017

0 references

cites work

Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport

1 reference

https://api.crossref.org/works/10.1007%2FS11910-008-0066-2

The clinical course of neuromyelitis optica (Devic's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-008-0066-2

Recurrent optic neuromyelitis with endocrinopathies: a new syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-008-0066-2

An open label study of the effects of rituximab in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-008-0066-2

Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease)

21 January 2018

1 reference

12 December 2020

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.

1 reference

12 December 2020

Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis

1 reference

12 December 2020

Devic's neuromyelitis optica treated with intravenous gamma globulin (IVIG).

1 reference

12 December 2020

Fulminant Devic disease successfully treated by lymphocytapheresis

1 reference

12 December 2020

Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients

1 reference

12 December 2020

Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.

1 reference

12 December 2020

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

1 reference

12 December 2020

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

1 reference

12 December 2020

Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays

1 reference

12 December 2020

Brain abnormalities in neuromyelitis optica

1 reference

12 December 2020

Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter

1 reference

12 December 2020

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.

1 reference

12 December 2020

Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report

1 reference

12 December 2020

Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica

1 reference

12 December 2020

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

1 reference

12 December 2020

Revised diagnostic criteria for neuromyelitis optica

1 reference

12 December 2020

A secondary progressive clinical course is uncommon in neuromyelitis optica

1 reference

12 December 2020

NMO-IgG and Devic's neuromyelitis optica: a French experience.

1 reference

12 December 2020

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

1 reference

12 December 2020

Plasma exchange for severe attacks of CNS demyelination: predictors of response

1 reference

12 December 2020

The aquaporin family of water channels in kidney

1 reference

12 December 2020

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

1 reference

12 December 2020

Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination

1 reference

12 December 2020

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

1 reference

12 December 2020

Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica

1 reference

12 December 2020

Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders

1 reference

12 December 2020

NMO-IgG predicts the outcome of recurrent optic neuritis

1 reference

12 December 2020

NMO antibody-positive recurrent optic neuritis without clear evidence of transverse myelitis

1 reference

12 December 2020

1 reference

12 December 2020

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.

1 reference

12 December 2020

Water movements in the brain: role of aquaporins.

1 reference

12 December 2020

Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis.

1 reference

12 December 2020

Lymphocytaplasmapheresis in Devic's syndrome

1 reference

12 December 2020

Hyperprolactinemia in multiple sclerosis.

1 reference

12 December 2020

Neuromyelitis optica with hypothalamic involvement

1 reference

12 December 2020

Hyperprolactinemia in optico-spinal multiple sclerosis

1 reference

12 December 2020

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.

1 reference

12 December 2020

Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).

1 reference

12 December 2020

Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine

1 reference

12 December 2020

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

1 reference

12 December 2020

Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica.

1 reference

12 December 2020

Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes.

1 reference

12 December 2020

10.1007/S11910-008-0066-2

Identifiers

DOI

1 reference

PubMed ID

18713580

Dimensions Publication ID

29 June 2017

0 references

1 reference

PubMed ID

18713580